Immunizations - Hoffman Flashcards
Intramuscular (IM) Route of Vaccine Administration
Upper thigh in infants, deltoid when muscle mass is sufficient
***Buttock should be avoided due to sciatic nerve damage and inconsistent IM deposition
- Hep A & B
- DTap/Dtap
- Hib
- Strep
- IPV
- Influenza
- Meningococcal
- HPV
Subcutaneous (SQ) Route of Vaccine Administration
Usually “pinch” the skin and inject into fatty tissue under the skin.
MMR & Varicella
Pneumococcal Conjugate Vaccine (PCV) Types
23-valent pneumococcal polysaccharide (23-PS) available (>2 years)
FDA licensed new 7-valent pneumococcal conjugate vaccine (PCV7) - < 2 years
Prevnar 13 – a 13-valent pneumococcal conjugate vaccine (PCV13)
Pneumococcal Conjugate Vaccine (PCV): Contraindications/Precuations
- known hypersensitivity
- moderate to severe illness
Pneumococcal Conjugate Vaccine (PCV): Side Effects
- Local erythema
- Induration
- Tenderness
- Fussiness
- Low grade to moderate fever
MMR Vaccine
Measles, Mumps, Rubella
Administration
- Given subcutaneously
- 1st dose: 12-15 months (minimum age is 12 months)
- 2nd dose: 4-6 years (at school entry)
MMR Vaccine
Measles, Mumps, Rubella
Contraindications & Precuations
Contraindications:
- Anaphylaxis
- Pregnancy
- Immunodeficiency
Precautions:
- Recent immune globulin administration
- History of thrombocytopenia
MMR Vaccine
Measles, Mumps, Rubella
Side Effects:
- Local tenderness/swelling
- Fever 7-10 days after
- Morbiliform rash
Active Immunity
Vaccination with live, live attenuated, or inactivated organisms, their components or their products to stimulate protective immunologic response
Contraindications for All Vaccines
Anaphylactic reaction to previous doses is an absolute contraindication for further doses
Anaphylactic reaction to any component
Moderate to severe illness with or without fever
Rotavirus Vaccine
Pentavalent Rotavirus Vaccine
Adminster three primary doses at 2, 4 and 6 months
***Should not be initiated after age 12 weeks and not to be given at all after 32 weeks of age
Meningococcal Vaccine - MPSV 4
Children age 2-10 in susceptible children
- Complement deficiency
- Anatomic or functional asplenia
- Other high-risk groups
Varicella Vaccine:
**Administration **
- live, attenuated virus
- 1st dose - 12-18 months or teens and adults with no history of natural infection
- 2nd dose – 4-6 years (new for 2007) 95% seroconvert after 1 dose
- >13 years, 2nd dose 4-8 weeks later
Varicella Vaccine:
Side Effects
- Local tenderness
- varicelliform rash within 1 month
Influenza Vaccine
Administration
- First dose: 6 months
- Dose yearly – vaccine typically updated.
- After age 2, option of live-attenuated (nasal spray).